Healthcare

Global Cardiac Biomarkers Market Size study, by type (Myocardial muscle Creatine Kinase, Myoglobin, Troponins (T and I), Ischemia Modified Albumin (IMA), Brain Natriuretic Peptide (BNPs) or NT-proBNP and Others) Application (myocardial infarction, congestive heart failure, acute coronary syndrome, Atherosclerosis, other applications) Location of Testing (point of care testing and laboratory testing) and Regional Forecasts 2018-2025.

  • BIZ2954244
  • 200 Pages
  • February 2019
  • Healthcare
Download Sample    Get Discount   
 
Global cardiac biomarkers market to reach USD 4,957.1 million by 2025.

Global cardiac biomarkers market is valued at approximately USD 1,241 million in 2017 and is anticipated to grow with a healthy growth rate of more than 18.9 % over the forecast period 2018-2025. Rising prevalence of cardiovascular diseases cost effective device, non-invasive method, accuracy in prediction, helpful in clinical trials, multi-application, increasing point of care application along with the technological advancements using cardiac biomarkers are some key trends that are responsible for the wide adoption of cardiac biomarkers globally.

Global cardiac biomarker market is majorly driven by rising prevalence of cardiovascular diseases. Cardiovascular diseases such as circulatory diseases, heart attacks and strokes are the leading cause for the premature death across the world. Cardiovascular diseases are caused by rising stress level and work pressure, harmful use of alcohol, unhealthy diet, obesity, tobacco use, and physical inactivity and it is most popular in aging population. Thus, cardiovascular diseases are the major cause of death across the globe. According the World Health Organization (WHO), in 2015 around 17.7million people died from cardiovascular diseases, signifying 31 % of global deaths, out of these 7.4million died due to coronary heart disease and 6.7 million died due to stroke across the world. As a result, the demand & adoption of cardiac biomarker would increase thereby, aiding the growth of the market over the forecast period of 2018-2025. Key market challenge for the global cardiac biomarker market is approval clinical validity and utility of biomarkers- based tests. However, to overcome this challenge the market also has various opportunities such as point of care testing using cardiac biomarkers, future developments in novel cardiac biomarkers and demand of personalized medicine.

On the basis of segmentation, the cardiac biomarkers market is segmented into type, application and location of testing. The type segment of global Cardiac Biomarkers market is classified into creatine Kinase (CK-MB), Troponins (T.I), myoglobin, Natriuretic Peptides (BNP & NT-PROBNP), ischemia modified albumin, others. Based on application segment the global cardiac biomarkers market is classified into myocardial infarction, congestive heart failure, acute coronary syndrome, Atherosclerosis, other applications of which myocardial infarction holds the highest share in the global cardiac biomarkers market due to high prevalence of cardiovascular diseases. The location of testing segment includes point of care testing and laboratory testing of which point of care accounts for the fastest growing segment due to clinicians and doctors mainly use point of care cardiac testing for quick testing and monitoring patients who are having chest pain.

The regional analysis of cardiac biomarkers market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America have occupied major share in the global cardiac biomarkers market. The major reasons for the dominance of North America are high CVD prevalence rates, high demand for cardiac testing and rising awareness towards cardiac diagnostics solutions. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific region is witnessed owing to rising affordability for the advanced cardiac treatments, modernization in the countries and increasing disposable income.

The leading market players include-

? Roche Diagnostics

? Abbott Laboratories,

? Siemens Healthcare,

? Alere Inc.,

? Becton, Dickinson and Company,

? Bio-Rad Laboratories,

? BioMerieux,

? Randox laboratories,

? Beckman Coulter

? Thermo Fisher Scientific

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

? Myocardial muscle Creatine Kinase (CK-MB)

? Myoglobin

? Troponins (T and I)

? Ischemia Modified Albumin (IMA)

? Brain Natriuretic Peptide (BNPs) or NT-proBNP

? Others

By Application:

? Congestive Heart Failure

? Myocardial Infarction

? Atherosclerosis

? Acute Coronary Syndrome

? Others

By Location of testing:

? Laboratory testing

? Point of care testing

By Regions:

? North America

o U.S.

o Canada

? Europe

o UK

o Germany

o ROE

? Asia Pacific

o China

o India

o Japan

o ROAPEC

? LAMEA

o Brazil

o Mexico

? ROW

o Middle East & Africa

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016

Base year – 2017

Forecast period – 2018 to 2025

Target Audience of the Global Cardiac Biomarkers Market in Market Study:

? Key Consulting Companies & Advisors

? Large, medium-sized, and small enterprises

? Venture capitalists

? Value-Added Resellers (VARs)

? Third-party knowledge providers

? Investment bankers

? Investors

TABLE OF CONTENTS

Chapter 1. Global Cardiac Biomarkers Market Definition and Scope

1.1. Research Objective

1.2. Market Definition

1.3. Scope of The Study

1.4. Years Considered for The Study

1.5. Currency Conversion Rates

1.6. Report Limitation

Chapter 2. Research Methodology

2.1. Research Process

2.1.1. Data Mining

2.1.2. Analysis

2.1.3. Market Estimation

2.1.4. Validation

2.1.5. Publishing

2.2. Research Assumption

Chapter 3. Executive Summary

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

3.2. Key Trends

Chapter 4. Global Cardiac Biomarkers Market Dynamics

4.1. Growth Prospects

4.1.1. Drivers

4.1.2. Restraints

4.1.3. Opportunities

4.2. Industry Analysis

4.2.1. Porter’s 5 Force Model

4.2.2. PEST Analysis

4.2.3. Value Chain Analysis

4.3. Analyst Recommendation & Conclusion

Chapter 5. Global Cardiac Biomarkers Market, By Type

5.1. Market Snapshot

5.2. Market Performance - Potential Model

5.3. Global Cardiac Biomarkers Market, Sub Segment Analysis

5.3.1. Myocardial muscle Creatine Kinase (CK-MB)

5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.2. Myoglobin

5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.3. Troponins (T and I)

5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.4. Ischemia Modified Albumin (IMA)

5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.5. Brain Natriuretic Peptide (BNPs) or NT-proBNP

5.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.6. Others

5.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Global Cardiac Biomarkers Market, By Application

6.1. Market Snapshot

6.2. Market Performance - Potential Model

6.3. Global Cardiac Biomarkers Market, Sub Segment Analysis

6.3.1. Congestive Heart Failure

6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.2. Myocardial Infarction

6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.3. Atherosclerosis

6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.4. Acute Coronary Syndrome

6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.5. Others

6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Global Cardiac Biomarkers Market, By Location Testing

7.1. Market Snapshot

7.2. Market Performance - Potential Model

7.3. Global Cardiac Biomarkers Market, Sub Segment Analysis

7.3.1. Laboratory testing

7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.2. Point of care testing

7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Global Cardiac Biomarkers Market, by Regional Analysis

8.1. Cardiac Biomarkers Market, Regional Market Snapshot (2015-2025)

8.2. North America Cardiac Biomarkers Market Snapshot

8.2.1. U.S.

8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2. Canada

8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3. Europe Cardiac Biomarkers Market Snapshot

8.3.1. U.K.

8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2. Germany

8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3. Rest of Europe

8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4. Asia Cardiac Biomarkers Market Snapshot

8.4.1. China

8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2. India

8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3. Japan

8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4. Rest of Asia Pacific

8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5. Latin America Cardiac Biomarkers Market Snapshot

8.5.1. Brazil

8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2. Mexico

8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6. Rest of The World

8.6.1. Middle East and Africa

8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9. Competitive Intelligence

9.1. Company Market Share (Subject to Data Availability)

9.2. Top Market Strategies

9.3. Company Profiles

9.3.1. Roche Diagnostics

9.3.1.1. Overview

9.3.1.2. Financial (Subject to Data Availability)

9.3.1.3. Product Summary

9.3.1.4. Recent Developments

9.3.2. Abbott Laboratories,

9.3.3. Siemens Healthcare,

9.3.4. Alere Inc.,

9.3.5. Becton, Dickinson and Company,

9.3.6. Bio-Rad Laboratories,

9.3.7. BioMerieux,

9.3.8. Randox laboratories,

9.3.9. Beckman Coulter

9.3.10. Thermo Fisher Scientific.

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CARDIAC BIOMARKERS MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CARDIAC BIOMARKERS MARKET

TABLE 3. GLOBAL CARDIAC BIOMARKERS MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)

TABLE 7. GLOBAL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)

TABLE 8. GLOBAL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY APPLICATION 2015-2025 (USD BILLION)

TABLE 9. GLOBAL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY LOCATION OF TESTING 2015-2025 (USD BILLION)

TABLE 10. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 11. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 12. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 13. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 14. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 15. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 16. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 17. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 18. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 19. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 20. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 21. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 22. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 23. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 24. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 25. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 26. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 27. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 28. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 29. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 30. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 31. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 32. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 33. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 34. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 35. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 36. U.S. CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 37. U.S CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 38. U.S CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 39. U.S CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 40. CANADA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 41. CANADA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 42. CANADA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 43. CANADA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 44. UK CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 45. UK CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 46. UK CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 47. UK CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 48. GERMANY CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 49. GERMANY CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 50. GERMANY CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 51. GERMANY CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 52. ROE CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 53. ROE CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 54. ROE CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 55. ROE CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 56. CHINA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 57. CHINA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 58. CHINA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 59. CHINA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 60. INDIA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 61. INDIA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 62. INDIA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 63. INDIA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 64. JAPAN CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 65. JAPAN CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 66. JAPAN CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 67. JAPAN CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 68. ROAPAC CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 69. ROAPEC CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 70. ROAPEC CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 71. ROAPEC CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 72. BRAZIL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 73. BRAZIL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 74. BRAZIL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 75. BRAZIL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 76. MEXICO CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 77. MEXICO CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 78. MEXICO CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 79. MEXICO CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 80. MIDDLE EAST & AFRICA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 81. MIDDLE EAST & AFRICA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 82. MIDDLE EAST & AFRICA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 83. MIDDLE EAST & AFRICA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370